Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.825
-0.022 (-2.59%)
At close: Feb 21, 2025, 4:00 PM
0.800
-0.024 (-2.97%)
After-hours: Feb 21, 2025, 6:37 PM EST
Renovaro Employees
Renovaro had 25 employees as of June 30, 2024. The number of employees increased by 13 or 108.33% compared to the previous year.
Employees
25
Change (1Y)
13
Growth (1Y)
108.33%
Revenue / Employee
n/a
Profits / Employee
-$4,736,418
Market Cap
130.93M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
RENB News
- 6 weeks ago - PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI - Business Wire
- 6 weeks ago - Renovaro Appoints Nathen Fuentes as Chief Financial Officer - GlobeNewsWire
- 6 weeks ago - Renovaro Issues Shareholder Letter and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Renovaro to Acquire Predictive Oncology in All-Stock Transaction - GlobeNewsWire
- 7 weeks ago - Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV - GlobeNewsWire
- 2 months ago - RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program - GlobeNewsWire
- 2 months ago - Renovaro Regains Compliance with NASDAQ Listing Requirement - GlobeNewsWire
- 2 months ago - Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection - GlobeNewsWire